<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>25437458</identifier>
<setSpec>1578-8989</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Escalada, Francisco Javier</dc:author>
<dc:description xml:lang="en">The hormone glucagon-like peptide-1 (GLP-1) is synthesized and secreted by L cells in the small intestine in response to food ingestion. After reaching the general circulation it has a half-life of 2-3 minutes due to degradation by the enzyme dipeptidyl peptidase-4. Its physiological role is directed to control plasma glucose concentration, though GLP-1 also plays other different metabolic functions following nutrient absorption. Biological activities of GLP-1 include stimulation of insulin biosynthesis and glucose-dependent insulin secretion by pancreatic beta cell, inhibition of glucagon secretion, delay of gastric emptying and inhibition of food intake. GLP-1 is able to reduce plasma glucose levels in patients with type 2 diabetes and also can restore beta cell sensitivity to exogenous secretagogues, suggesting that the increasing GLP-1 concentration may be an useful therapeutic strategy for the treatment of patients with type 2 diabetes.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:subject>Obesidad</dc:subject>
<dc:subject>Obesity</dc:subject>
<dc:subject>GLP-1</dc:subject>
<dc:subject>Glucagon</dc:subject>
<dc:subject>DPP-4</dc:subject>
<dc:subject>Glucagón</dc:subject>
<dc:subject>Gastric emptying</dc:subject>
<dc:subject>Type 2 diabetes mellitus</dc:subject>
<dc:subject>Vaciamiento gástrico</dc:subject>
<dc:subject>Insulin</dc:subject>
<dc:subject>GIP</dc:subject>
<dc:subject>Análogos del GLP-1</dc:subject>
<dc:subject>Insulina</dc:subject>
<dc:subject>Beta cell</dc:subject>
<dc:subject>Diabetes mellitus tipo 2</dc:subject>
<dc:subject>GLP-1 analogs</dc:subject>
<dc:subject>Célula beta</dc:subject>
<dc:date>2014 Sep </dc:date>
<dc:title xml:lang="es">Fisiología del GLP-1 y su papel en la fisiopatología de la diabetes mellitus tipo 2.</dc:title>
<dc:title xml:lang="en">[The physiology of glucagon-like peptide-1 and its role in the pathophysiology of type 2 diabetes mellitus].</dc:title>
<dc:publisher>Medicina clinica</dc:publisher>
</metadata>
</record>
</pubmed-document>
